Status:
TERMINATED
The Role of Platelet Rich Plasma for Erectile Dysfunction
Lead Sponsor:
University of Nebraska
Conditions:
Erectile Dysfunction
Eligibility:
MALE
50-80 years
Phase:
PHASE3
Brief Summary
Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.
Detailed Description
Eligibility: Men with erectile dysfunction. Ages 50-80. International Index of Erectile Function score of mild (17-21/25) or moderate (8-16/25). Intervention and Evaluation:Men who consent to join th...
Eligibility Criteria
Inclusion
- history of mild to moderate erectile dysfunction measured by IIEF
Exclusion
- history or prostate cancer treatment (prostatectomy, radiation, brachytherapy)
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2022
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04357353
Start Date
April 1 2021
End Date
November 2 2022
Last Update
August 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unversity of Nebraska Medical Center
Omaha, Nebraska, United States, 68198